By purchasing SignalPath, Verily aims to strengthen its existing clinical trial system, Baseline, which supports clinical trial execution, improved data aggregation and analysis, and flexible study options to accommodate hybrid trials, among other features.
SignalPath’s platform helps research sites improve their costs while reducing the complexities and time associated with trials, according to the news release.
SignalPath co-founder and CEO Brad Hirsch, MD, will remain part of the company while SignalPath’s 100 employees join Verily’s clinical research business.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
